4//SEC Filing
COLEMAN KIRK ALLEN 4
Accession 0001213900-21-010414
CIK 0001733413other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 7:02 PM ET
Size
9.0 KB
Accession
0001213900-21-010414
Insider Transaction Report
Form 4
COLEMAN KIRK ALLEN
CFO, Secretary, and Treasurer
Transactions
- Exercise/Conversion
Common Stock
2021-02-16$2.50/sh+5,000$12,500→ 6,000 total - Sale
Common Stock
2021-02-16$16.82/sh−5,000$84,100→ 1,000 total - Exercise/Conversion
Stock Options (Right to Buy)
2021-02-16−5,000→ 282,883 totalExercise: $2.50From: 2020-04-11Exp: 2029-04-11→ Common Stock (5,000 underlying)
Footnotes (3)
- [F1]The transactions reported by this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2020.
- [F2]The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options.
- [F3]37,500 shares of common stock vested on April 11, 2020 and the remainder of the shares vested at an approximate rate of 9,375 every three months thereafter.
Documents
Issuer
TFF Pharmaceuticals, Inc.
CIK 0001733413
Entity typeother
Related Parties
1- filerCIK 0001790624
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 7:02 PM ET
- Size
- 9.0 KB